Evidence map›Paper›PMID 29604112›Full record

ArticleJournal of clinical laboratory analysis2018

CYP2E1 and GSTM1 gene polymorphisms, environmental factors, and the susceptibility to lung cancer.

Qingfang He, Lixin Wang, Jie Zhang, Feng Lu, Weiwei Gong, Jin Pan, Jieming Zhong, Ruying Hu, Min Yu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Qingfang HeZhejiang Provincial Center for Disease Prevention and Control, Hangzhou, China.ORCID http://orcid.org/0000-0002-2021-4431
Lixin WangZhejiang Provincial Center for Disease Prevention and Control, Hangzhou, China.
Jie ZhangZhejiang Provincial Center for Disease Prevention and Control, Hangzhou, China.
Feng LuZhejiang Provincial Center for Disease Prevention and Control, Hangzhou, China.
Weiwei GongZhejiang Provincial Center for Disease Prevention and Control, Hangzhou, China.
Jin PanZhejiang Provincial Center for Disease Prevention and Control, Hangzhou, China.
Jieming ZhongZhejiang Provincial Center for Disease Prevention and Control, Hangzhou, China.
Ruying HuZhejiang Provincial Center for Disease Prevention and Control, Hangzhou, China.
Min YuZhejiang Provincial Center for Disease Prevention and Control, Hangzhou, China.
Zhejiang Center for Disease Control and Prevention · CN

Funding

Medical and Health Major Science Research Fund of Zhejiang Province WKJ-ZJ-1506Qianjiang Talents Project of Science Technology Department of Zhejiang Province 2013R10078
6 · The paper itself

Abstract

objectiveTo investigate the relationships between the CYP2E1 RsaI polymorphism, GSTM1 polymorphism, and the susceptibility to lung cancer, along with the interactions between environmental factors and these genes.

methodsA case-control study was carried out to explore the independent effect of gene polymorphisms on risk of lung cancer, and the combined effects of gene loci. The stratification analysis of age, sex, smoking, and drinking combined with positive loci was also analyzed, and any interaction was identified.

resultsThe logistic regression analysis showed that there were statistical relationships between the CYP2E1 RsaI TT genotype and lung cancer, GSTM1 (-) and lung cancer. The combined effect's analysis of these 2 loci showed that, with an increase in the number of risk alleles, the risk of lung cancer also increased (supposing 0 risk allele as the reference group). Subjects carrying 3 risk alleles had the highest risk of developing lung cancer with an adjusted OR = 10.38 (95% CI 2.10-51.35). Stratified analysis showed that, in women, nonsmoking subjects, or nondrinking subjects, the combined effects could increase the risk of lung cancer; no heterogeneity was found between these layers except sex. The interaction analysis showed that, supposing the male, GSTM1 (+) genotype as the reference, the female, GSTM1 (-) genotype had a significantly increased risk of lung cancer (OR = 2.17 [1.01-4.70]); when the non-smoking, GSTM1 (+) genotype subjects was the reference group, smoking, GSTM1 (+) genotype subjects and smoking, GSTM1 (-) genotype subjects had significantly higher risk of lung cancer (OR = 2.00 [1.01-3.96], OR = 2.89 [1.28-6.54]).

conclusionCYP2E1 RsaI TT genotype was a protective factor against the development of lung cancer, while GSTM1 (-) genotype was a risk factor for lung cancer. Increases in the number of the risk alleles also increased lung cancer risk. GSTM1 (-) genotype, sex, and smoking status might interact in the incidence of lung cancer.

Indexed as

gene polymorphismlung cancermetabolic enzymesmokingsusceptibility

Identifiers

PMID29604112
PMCPMC6817220
OpenAlexW2794884826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.